9 research outputs found
Mejora de la Linealidad de un amplificador de Potencia para un Sistema EER Mediante Predistorsion Digital
En este trabajo se presenta un amplificador de potencia de RF linealizado mediante la combinaci n de t cnicas de Eliminaci n y Recuperaci n de Envolvente (EER) y Predistorsi n. Se utiliza para ello procesado digital de la se al en banda base y la identificaci n de modelos en el dominio del tiempo para describir el funcionamiento del amplificador de potencia. Empleando m todos basados en la t cnica de error de salida, se calcula e implementa la funci n complementaria no lineal del amplificador de potencia de RF del sistema EER en Matlab, para su posterior linealizaci n. Se han conseguido mejoras de hasta 20 dB usando esta t cnica con respecto a un sistema EER sin linealizar
Amplificador de potencia Clase F en banda L basado en tecnologĂa GaN
This paper reports a high efficiency class-F power amplifier based on a gallium nitride high electron mobility transistor (GaN-HEMT), which is designed at the L band of 1640 MHz. The design is based on source and load pull measurements. During the design process, the parasitics of the package of the device are also taken into account in order to achieve the optimal class-F load condition at the intrinsic drain of the transistor. The fabricated class-F power amplifier achieved a maximum drain efficiency (DE) of 77.8% and a output power of 39.6 W on a bandwidth of 280 MHz. Simulation and measurement results have shown good agreement
Predistorsion Digital Aplicada al Amplificador de Potencia de un Sistema EER
A linealized RF power amplifier using Envelope Elimination and Restoration (EER) and predistortion techniques is shown. Measurements on a circuit prototype are presented. The EER system uses a linear regulator to amplify the envelope and a high efficiency broadband VHF class E power amplifier for the phase component. Different digital modulations have been tested in the circuit prototype. Adjacent Channel Power Ratio (ACPR) reaches over 46 dBc for monocarrier modulations and over 34 dBc for multicarrier modulations, for a 2MHz bandwidth on VHF carrier (from 88 MHz to 114 MHz). The system shown provides double efficiency level than an equivalent ideal class A amplifier
Procedimiento De Amplificador De Envolvente De Señales Moduladas En RF Para Técnicas EER Y ET
An envelope amplifier for an EER (Envelope Elimination and Restoration) and ET (Envelope Tracking) techniques is shown in this paper. The amplifier is based on a high speed two phases buck converter and employs RF LDMOS technology for the switching stage. A DPWM (Digital Pulse With Modulation) signal is used to control the amplifier by means of a functions generator. Simulations and measurements on a circuit prototype are presented showing a good agreement. Up to 125W output peak power can be delivered over a 5Ω load resistor. About 80% efficiency has been obtained. And at the two tone test, the third order intermodulation products (IP3) remain below 45dBc over a 2MHz bandwidth
Amplificador de potencia clase F a 1.64 ghz con control de armĂłnicos
This paper presents a high-power high efficiency PA design method using load pull technique. Harmonic impedance control at the virtual drain is accomplished through the use of tunable pre-matching circuits and modeling of package parasitics. A 0.5 µm GaN high electron mobility transistor (HEMT) is characterized using the method, and loadpull measurements are simulated illustrating the impact of varying 2nd and 3rd harmonic termination. These harmonic terminations are added to satisfy conditions for class-F load pull. The method is verified by design and simulation of a 40-W class-F PA prototype at 1.64 GHz with 76% drain efficiency and 10 dB gain (70% PAE)
Amplificador de envolvente de señales de RF basado en el convertidor buck multifase
En este trabajo se presenta un convertidor DC-DC buck de dos fases de alta velocidad adecuado para emplear en tĂ©cnicas de linealizaciĂłn de amplificadores como ET (Envelope Tracking) o EER (Envelope Elimination and Restoration). El convertidor ha sido realizado con tecnologĂa LDMOS y la tĂ©cnica usada para controlarlo ha sido modulaciĂłn PWM, creada mediante procesado digital y un generador de funciones. La potencia de salida es de hasta 125W de pico, con un rendimiento del 80%, un ancho de banda de hasta 2MHz y en las medidas de linealidad presenta una atenuaciĂłn a los productos de intermodulaciĂłn de tercer orden de más de 45 dBc
Integración de un amplificador de RF de alto rendimiento con un amplificador de envolvente con red de cancelación de rizado mediante la técnica de EER
En este artĂculo se presenta la integraciĂłn de un amplificador de envolvente de una etapa con un amplificador de clase E mediante la tĂ©cnica de Kahn o EliminaciĂłn y restauraciĂłn de envolvente (EER). Esta tĂ©cnica se basa en la combinaciĂłn de un amplificador de potencia conmutado de alto rendimiento alimentado por una fuente de alimentaciĂłn modulada. El amplificador de envolvente se ha implementado con un convertidor reductor sĂncrono con red de cancelaciĂłn de rizado, lo cual permite reducir la relaciĂłn entre la frecuencia de conmutaciĂłn y el ancho de banda de gran señal del amplificador de envolvente, que es uno de los factores de diseño más limitantes en esta aplicaciĂłn. Para la mejora de la linealidad se ha usado la tĂ©cnica de predistorsiĂłn realizándose una validaciĂłn experimental. El amplificador de envolvente conmuta a 4MHz y el amplificador de clase E a 100MHz. El rendimiento total obtenido para una modulaciĂłn de amplitud en cuadratura (QAM) es del 68%, con un relaciĂłn de potencia del canal adyacente (ACPR) de 40dB. Para una modulaciĂłn por multiplexaciĂłn por divisiĂłn de frecuencias ortogonales (OFDM), se ha obtenido un rendimiento total del 57% y un ACPR de 32dB.
Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study
Summary
Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally.
Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies
have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of
the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income
countries globally, and identified factors associated with mortality.
Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to
hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis,
exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a
minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical
status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary
intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause,
in-hospital mortality for all conditions combined and each condition individually, stratified by country income status.
We did a complete case analysis.
Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital
diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal
malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome
countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male.
Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3).
Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income
countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups).
Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome
countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries;
p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients
combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11],
p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20
[1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention
(ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety
checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed
(ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of
parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65
[0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality.
Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome,
middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will
be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger
than 5 years by 2030
The Immune Microenvironment Landscape of Pituitary NeuroEndocrine Tumors, a Transcriptomic Approach
Pituitary neuroendocrine tumors (PitNET) are known to be variably infiltrated by different immune cells. Nonetheless, their role in pituitary oncogenesis has only begun to be unveiled. The immune microenvironment could determine the biological and clinical behavior of a neoplasm and may have prognostic implications. To evaluate the expression of immune-related genes and to correlate such expression with the presence of infiltrating immune cells in forty-two PitNETs of different lineages, we performed whole transcriptome analysis and RT-qPCR. Deconvolution analysis was carried out to infer the immune cell types present in each tumor and the presence of immune cells was confirmed by immunofluorescence. We found characteristic expression profiles of immune-related genes including those encoding interleukins and chemokines for each tumor lineage. Genes such as IL4-I1, IL-36A, TIRAP, IL-17REL, and CCL5 were upregulated in all PitNETS, whereas IL34, IL20RA, and IL-2RB characterize the NR5A1-, TBX19-, and POU1F1-derived tumors, respectively. Transcriptome deconvolution analysis showed that M2 macrophages, CD4+ T cells, CD8+ T cells, NK cells, and neutrophils can potentially infiltrate PitNET. Furthermore, CD4+ and CD8+ T cells and NK cells infiltration was validated by immunofluorescence. Expression of CCL18, IL-5RA, and HLA-B as well as macrophage tumor infiltration could identify patients who can potentially benefit from treatment with immune checkpoint inhibitors